SCHEMBL1970376

SCHEMBL1970376

N#CC1=CNCC2=C1CCNC2

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PNMT P11086 3/20 0.36
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23706719 0.59
SCHEMBL24510333 0.57 MEN1 (0.32)
Potassium Ion SCHEMBL29475097 0.56 PNMT (0.36) PNMTDRD2DRD3
SCHEMBL21605445 0.56 DRD2 (0.36) PNMTDRD2DRD3
SCHEMBL2115873 0.55
SCHEMBL22908212 0.55
SCHEMBL22488571 0.55
SCHEMBL25281145 0.55 PNMT (0.46) PNMTDRD2DRD3
SCHEMBL22482053 0.54 HTR2A (0.40) PNMTDRD2DRD3
SCHEMBL22269214 0.54 MAOB (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334676-A1 SUBSTITUTED 3 -AMIN0- 1-0X0 OR THIOXO-I, 2,5,6,7, 8-HEXAHYDR0-2, 7-NAPHTHYRIDINE-4-CARB0NITRILES AS SELECTIVE ALPHA 2B ANTAGONISTS Allergan, Inc. (US) 2011-06-22 EP disclosed
WO-2010033393-A1 SUBSTITUTED 3 -AMIN0- 1-0X0 OR THIOXO-I, 2,5,6,7, 8-HEXAHYDR0-2, 7-NAPHTHYRIDINE-4-CARB0NITRILES AS SELECTIVE ALPHA 2B ANTAGONISTS ALLERGAN, INC. (US) 2010-03-25 WO disclosed